Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 15, 2010

Drug Name Review Type Class Manufacturer
Zirgan New Drug Initial Review Antiviral Bausch & Lomb
Oravig New Drug Initial Review Antifungal Strativa
Cetraxal New Drug Initial Review Otic Antibiotic Wraser
Lysteda New Drug Initial Review Antifibrinolytic Ferring
Oleptro New Drug Initial Review Antidepressant Labopharm
Pancreaze New Drug Initial Review Pancreatic Enzyme OMJPI
Xifaxan 550 New Drug Appeal Antibiotic Salix
Bepreve New Drug Appeal Ophthalmic- Allergic Conjunctivitis Ista
Colcrys New Drug Appeal Anti-Gout URL
Fanapt New Drug Appeal Atypical Antipsychotic Novartis
Pristiq New Drug Appeal SNRI Antidepressant Pfizer
Saphris PDL Appeal Atypical Antipsychotic Merck
Vesicare PDL Appeal Urinary Anti-Incontinence Astellas